Prometheus Biosciences, Inc., (RXDX) Stock Charts RXDX Home News Ratings Charts Price Target Warning: This security is no longer trading. Roche has completed deal to acquire Ignyta, Inc. Prometheus Biosciences, Inc., (RXDX): $199.92 0.18 (+0.09%) POWR Rating Get Rating Component Grades Growth Get Rating Value Get Rating Momentum NR Stability NR Sentiment Get Rating Quality NR Add RXDX to Watchlist Sign Up Industry: Biotech Industry NR Ranked in industry See All 'A' Rated Buy Stocks Prometheus Biosciences, Inc., (RXDX) Performance Graph for POWR Ratings Prometheus Biosciences, Inc., (RXDX) Interactive Chart RXDX Chart by TradingView Prometheus Biosciences, Inc., (RXDX) Ratings History Chart Free access to the full ratings history for RXDX. Sign up now! Most Popular Stories View All • How Low Could Stocks Go? • 3 Biotech Stocks to Buy to Power Through April • Check out These 3 Internet Stocks for Potential Gains • Top 3 Financial Services Stocks With Unstoppable Momentum • Updated 2024 Stock Market Outlook View All Top stories Get Free Updates Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! Subscribe Get Free Updates Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
